167 related articles for article (PubMed ID: 16965218)
1. Aripiprazole augmentation of venlafaxine in the treatment of psychogenic excoriation.
Carter WG; Shillcutt SD
J Clin Psychiatry; 2006 Aug; 67(8):1311. PubMed ID: 16965218
[No Abstract] [Full Text] [Related]
2. Does aripiprazole protect from serotonin syndrome?
Rittmannsberger H; Werl R
Psychiatr Danub; 2012 Mar; 24(1):100-1. PubMed ID: 22447095
[No Abstract] [Full Text] [Related]
3. Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: a post-hoc, pooled analysis of two large, placebo-controlled studies.
Nelson JC; Mankoski R; Baker RA; Carlson BX; Eudicone JM; Pikalov A; Tran QV; Berman RM
J Affect Disord; 2010 Jan; 120(1-3):133-40. PubMed ID: 19656577
[TBL] [Abstract][Full Text] [Related]
4. The treatment of psychogenic excoriation and obsessive compulsive disorder using aripiprazole and fluoxetine.
Curtis AR; Richards RW
Ann Clin Psychiatry; 2007; 19(3):199-200. PubMed ID: 17729023
[No Abstract] [Full Text] [Related]
5. Effect of aripiprazole augmentation for treatment-resistant somatoform disorder: a case series.
Nagoshi Y; Tominaga T; Fukui K
J Clin Psychopharmacol; 2014 Jun; 34(3):397-8. PubMed ID: 24525655
[No Abstract] [Full Text] [Related]
6. Venlafaxine: Successful treatment in impulsive disorders.
Camardese G; Picello A; Bria P
Psychiatry Clin Neurosci; 2008 Apr; 62(2):241-2. PubMed ID: 18412851
[No Abstract] [Full Text] [Related]
7. Aripiprazole augmentation of clomipramine-refractory obsessive-compulsive disorder.
Friedman S; Abdallah TA; Oumaya M; Rouillon F; Guelfi JD
J Clin Psychiatry; 2007 Jun; 68(6):972-3. PubMed ID: 17592930
[No Abstract] [Full Text] [Related]
8. Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.
Sheffrin M; Driscoll HC; Lenze EJ; Mulsant BH; Pollock BG; Miller MD; Butters MA; Dew MA; Reynolds CF
J Clin Psychiatry; 2009 Feb; 70(2):208-13. PubMed ID: 19210951
[TBL] [Abstract][Full Text] [Related]
9. Aripiprazole augmentation for a patient with partial remission of panic disorder.
Harada T; Yamada K; Sakamoto K; Ishigooka J
J Clin Psychopharmacol; 2009 Jun; 29(3):301-2. PubMed ID: 19440089
[No Abstract] [Full Text] [Related]
10. Psychosis in the elderly.
Kyomen HH; Whitfield TH
Am J Psychiatry; 2009 Feb; 166(2):146-50. PubMed ID: 19188291
[No Abstract] [Full Text] [Related]
11. Remission of chronic severe selective serotonin-reuptake inhibitor/selective norepinephrine-reuptake inhibitor refractory depression following adjunctive aripiprazole.
Sokolski KN; Gripeos D
Ann Pharmacother; 2008 Sep; 42(9):1348-9. PubMed ID: 18682539
[No Abstract] [Full Text] [Related]
12. Venlafaxine and increased aggression in a female with autism.
Marshall BL; Napolitano DA; McAdam DB; Dunleavy III JJ; Tessing JL; Varrell J
J Am Acad Child Adolesc Psychiatry; 2003 Apr; 42(4):383-4. PubMed ID: 12649624
[No Abstract] [Full Text] [Related]
13. Aripiprazole augmentation in 13 patients with refractory obsessive-compulsive disorder: a case series.
Higuma H; Kanehisa M; Maruyama Y; Ishitobi Y; Tanaka Y; Tsuru J; Hanada H; Kodama K; Isogawa K; Akiyoshi J
World J Biol Psychiatry; 2012 Jan; 13(1):14-21. PubMed ID: 22256827
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder.
Papakostas GI; Petersen TJ; Kinrys G; Burns AM; Worthington JJ; Alpert JE; Fava M; Nierenberg AA
J Clin Psychiatry; 2005 Oct; 66(10):1326-30. PubMed ID: 16259548
[TBL] [Abstract][Full Text] [Related]
15. A case of unexpected and selective remission of a 20-year history of ephedrine dependence following treatment with low-dose aripiprazole.
Arnold KK; Yager J
J Clin Psychiatry; 2007 Oct; 68(10):1620-1. PubMed ID: 17960985
[No Abstract] [Full Text] [Related]
16. Two cases of olfactory reference syndrome responding to an atypical antipsychotic and SSRI.
Michael S; Boulton M; Andrews G
Aust N Z J Psychiatry; 2014 Sep; 48(9):878-9. PubMed ID: 24604919
[No Abstract] [Full Text] [Related]
17. An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder.
Menza MA; Dobkin RD; Marin H
J Clin Psychopharmacol; 2007 Apr; 27(2):207-10. PubMed ID: 17414231
[No Abstract] [Full Text] [Related]
18. Aripiprazole-associated leukopenia with coadministration of fluoxetine: a case report.
Huang LC; Chiang KT
J Clin Psychopharmacol; 2011 Jun; 31(3):376-7. PubMed ID: 21532363
[No Abstract] [Full Text] [Related]
19. Aripiprazole as an augmentation agent in treatment-resistant body dysmorphic disorder.
Uzun O; Ozdemir B
Clin Drug Investig; 2010; 30(10):707-10. PubMed ID: 20701402
[TBL] [Abstract][Full Text] [Related]
20. Possible neuroleptic malignant syndrome with aripiprazole and fluoxetine.
Duggal HS; Kithas J
Am J Psychiatry; 2005 Feb; 162(2):397-8. PubMed ID: 15677611
[No Abstract] [Full Text] [Related]
[Next] [New Search]
